Laurus Labs releases Consolidated Quarterly Results for March 31, 2023. Laurus Labs has announced an increase in total income from Rs. 1546.25 Crores as of December 31, 2022, to Rs. 1382.61 Crores as of March 31, 2023. The net profit for the company has decreased from Rs. 203.04 Crores as of December 31, 2022, to Rs. 102.98 Crores as of March 31, 2023. However, the earnings per share (EPS) have improved, increasing from Rs. 3.76 on December 31, 2022, to Rs. 1.90 on March 31, 2023, according to the company’s statement.
Laurus Labs Quarterly Results (Q4 FY2023) – Quarter-over-Quarter Comparison:
Total income of the company is Rs. 1382.61 Crores (March 31, 2023) vs. Rs. 1546.25 Crores (December 31, 2022)
Net profit/loss: Rs. 102.98 Crores (March 31, 2023) vs. Rs. 203.04 Crores (December 31, 2022)
EPS: Rs. 1.90 (March 31, 2023) vs. Rs. 3.76 Crores (December 31, 2022)
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹ 1382.61 Cr | ₹ 1546.25 Cr | ⬇ -10.58% |
| Net Profit | ₹ 102.98 Cr | ₹ 203.04 Cr | ⬇ -49.28% |
| EPS | ₹ 1.90 | ₹ 3.76 | ⬇ -49.47% |
Laurus Labs Quarterly Results (Q4 FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 1382.61 Crores (March 31, 2023) vs. Rs. 1426.12 Crores (March 31, 2022)
Net profit/loss: Rs. 102.98 Crores (March 31, 2023) vs. Rs. 230.50 Crores (March 31, 2022)
EPS: Rs. 1.90 (March 31, 2023) vs. Rs. 4.28 (March 31, 2022)
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹ 1382.61 Cr | ₹ 1426.12 Cr | ⬇ -3.05% |
| Net Profit | ₹ 102.98 Cr | ₹ 230.50 Cr | ⬇ -55.32% |
| EPS | ₹ 1.90 | ₹ 4.28 | ⬇ -55.61% |
Laurus Labs Quarterly Results (Year Ended FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 6046.55 Crores (March 31, 2023) vs. Rs. 4950.87 Crores (March 31, 2022)
Net profit/loss: Rs. 790.11 Crores (March 31, 2023) vs. Rs. 827.52 Crores (March 31, 2022)
EPS: Rs. 14.64 (March 31, 2023) vs. Rs. 15.35 (March 31, 2022)
| Financials | 12 Months Ended FY2023 | 12 Months Ended FY2022 | % Change |
| Total Income | ₹ 6046.55 Cr | ₹ 4950.87 Cr | ⬆ 22.13% |
| Net Profit | ₹ 790.11 Cr | ₹ 827.52 Cr | ⬇ -4.52% |
| EPS | ₹ 14.64 | ₹ 15.35 | ⬇ -4.63% |
Laurus Labs Share Dividend Announcement / Record Date:
The Board of Directors has declared a Final Dividend of ₹1.20 per Equity Share of Face Value of ₹2 each of the Company (60% of Face Value). Total Dividend for FY23 stood at ₹2 per Equity Share (Interim Dividend of ₹2 per Equity Share)
| Dividend | Record Date |
| ₹1.20 per Equity Share | After 18/05/2023 |
About Laurus Labs:
Hyderabad-based Laurus Labs is a multinational pharmaceutical and biotechnology company that specializes in active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs, and agrochemicals. The company was established in 2005 by Dr. Satyanarayana Chava.
Download Full PDF Q4 Results Laurus Labs:
For More Latest News Click Here
